0001209191-20-062100.txt : 20201207
0001209191-20-062100.hdr.sgml : 20201207
20201207213212
ACCESSION NUMBER: 0001209191-20-062100
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201203
FILED AS OF DATE: 20201207
DATE AS OF CHANGE: 20201207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hienrich Edi
CENTRAL INDEX KEY: 0001472187
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32381
FILM NUMBER: 201374232
MAIL ADDRESS:
STREET 1: 800 W. OLYMPIC BLVD., SUITE 406
CITY: LOS ANGELES
STATE: CA
ZIP: 90015
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HERBALIFE NUTRITION LTD.
CENTRAL INDEX KEY: 0001180262
STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: P.O. BOX 309GT
STREET 2: UGLAND HOUSE, SOUTH CHURCH STREET
CITY: GEORGE TOWN
STATE: E9
ZIP: 00000
BUSINESS PHONE: 310 410 9600
MAIL ADDRESS:
STREET 1: P.O. BOX 309GT
STREET 2: UGLAND HOUSE, SOUTH CHURCH STREET
CITY: GEORGE TOWN
STATE: E9
ZIP: 00000
FORMER COMPANY:
FORMER CONFORMED NAME: HERBALIFE LTD.
DATE OF NAME CHANGE: 20041214
FORMER COMPANY:
FORMER CONFORMED NAME: WH HOLDINGS CAYMAN ISLANDS LTD
DATE OF NAME CHANGE: 20020814
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-03
0
0001180262
HERBALIFE NUTRITION LTD.
HLF
0001472187
Hienrich Edi
800 W. OLYMPIC BLVD. SUITE 406
LOS ANGELES
CA
90015
0
1
0
0
SVP/Managing Director EMEA
Common Stock
2020-12-03
4
M
0
15000
23.90
A
48529
D
Common Stock
2020-12-03
4
F
0
10872
49.72
D
37657
D
Common Stock
2020-12-03
4
M
0
26872
31.255
A
64529
D
Common Stock
2020-12-03
4
F
0
21584
49.72
D
42945
D
Common Stock
2020-12-04
4
S
0
6241
49.88
D
36704
D
Common Stock
2020-12-07
4
S
0
9416
49.8756
D
27288
D
Common Stock
13819
I
By wife
Stock Appreciation Rights
23.90
2020-12-03
4
M
0
15000
0.00
D
2018-05-07
2025-05-07
Common Stock
15000
0
D
Stock Appreciation Rights
31.255
2020-12-03
4
M
0
26872
0.00
D
2019-05-09
2026-05-09
Common Stock
26872
0
D
This transaction was executed in multiple trades at prices ranging from $49.87 to $49.88. The price reported reflects the weighted average sale price of $49.8756. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The stock appreciation rights ("SARs") were previously reported as part of an award covering 12,500 shares at an exercise price of $47.80 per share.
The SARs were granted on May 7, 2015. 20% vested on May 7, 2016, 20% vested on May 7, 2017 and the remaining 60% vested on May 7, 2018.
Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The SARs were previously reported as part of an award covering 16,795 shares at an exercise price of $62.51 per share.
The SARs were granted on May 9, 2016. 20% vested on May 9, 2017, 20% vested on May 9, 2018 and the remaining 60% vested on May 9, 2019.
Lisa Kwon, as Attorney-in-Fact for Edi Hienrich
2020-12-07